Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide add-on with gefitinib or erlotinib in EGFR-mutated terminal-stage lung adenocarcinoma
KCT0001467Phase 2Completed
- Sponsor
- Rural Development Administration
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide in Non-small cell lung cancer adenocarcinoma (NSCLC), sponsored by Rural Development Administration. Started Mar 2015; status: completed.
02
Drugs
nicotinamide
03
Conditions
Non-small cell lung cancer adenocarcinoma (NSCLC)
Beyond the preview
Go deeper on KCT0001467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001467.